Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Venous Thrombosis

Free Subscription Articles published in N Engl J Med Retrieve available abstracts of 41 articles: HTML format

Single Articles

September 2026
1. ROSENFIELD K, Piazza G, Konstantinides SV
   Ultrasound-Facilitated, Catheter-Directed Fibrinolysis for Acute Pulmonary Embolism. Reply.
   N Engl J Med. 2026;395:1037.
   PubMed    
   
   
   
2. MARTIN KA, Bauer KA, Davidson BL
   Ultrasound-Facilitated, Catheter-Directed Fibrinolysis for Acute Pulmonary Embolism.
   N Engl J Med. 2026;395:1036-1037.
   PubMed    
   
   
   
3. MENESES DE AGUIAR JV, Barcellos LF, Gazzana MB
   Ultrasound-Facilitated, Catheter-Directed Fibrinolysis for Acute Pulmonary Embolism.
   N Engl J Med. 2026;395:1036.
   PubMed    
   
   
   
4. SOLIS RC, Moreno Hoyos-Abril F, Nanez-Terreros H
   Ultrasound-Facilitated, Catheter-Directed Fibrinolysis for Acute Pulmonary Embolism.
   N Engl J Med. 2026;395:1035-1036.
   PubMed    
   
   
   
5. SAUTHOFF H
   Ultrasound-Facilitated, Catheter-Directed Fibrinolysis for Acute Pulmonary Embolism.
   N Engl J Med. 2026;395:1035.
   PubMed    
   
   
   
6. BRASS EP
   Ultrasound-Facilitated, Catheter-Directed Fibrinolysis for Acute Pulmonary Embolism.
   N Engl J Med. 2026;395:1035.
   PubMed    
   
   
   August 2026
7. KROUPA J, Radvan M, Mrozek J, Sluka M, et al
   Catheter-Directed Thrombolysis in Intermediate-High-Risk Pulmonary Embolism.
   N Engl J Med. 2026 Aug 31. doi: 10.1056/NEJMoa2608012.
   PubMed     Abstract available
   
   
   June 2026
8. CASTELLUCCI LA, Le Gal G, Rodger M
   Bleeding Risk with Apixaban vs. Rivaroxaban in Acute Venous Thromboembolism. Reply.
   N Engl J Med. 2026;394:2278-2279.
   PubMed    
   
   
   
9. DESAI N
   Bleeding Risk with Apixaban vs. Rivaroxaban in Acute Venous Thromboembolism.
   N Engl J Med. 2026;394:2278.
   PubMed    
   
   
   
10. EDJIMBI J, Bakhshi H, Van Spall HGC
    Bleeding Risk with Apixaban vs. Rivaroxaban in Acute Venous Thromboembolism.
    N Engl J Med. 2026;394:2278.
    PubMed    
    
    
    
11. BRENNER MJ
    Bleeding Risk with Apixaban vs. Rivaroxaban in Acute Venous Thromboembolism.
    N Engl J Med. 2026;394:2277-2278.
    PubMed    
    
    
    
12. HARTEMINK J, Parker K, Mitra S
    Bleeding Risk with Apixaban vs. Rivaroxaban in Acute Venous Thromboembolism.
    N Engl J Med. 2026;394:2277.
    PubMed    
    
    
    
13. ADNAN N, Uzair K, Patel MJ
    Bleeding Risk with Apixaban vs. Rivaroxaban in Acute Venous Thromboembolism.
    N Engl J Med. 2026;394:2276-2277.
    PubMed    
    
    
    March 2026
14. ROSENFIELD K, Klok FA, Piazza G, Sharp ASP, et al
    Ultrasound-Facilitated, Catheter-Directed Fibrinolysis for Acute Pulmonary Embolism.
    N Engl J Med. 2026 Mar 28. doi: 10.1056/NEJMoa2516567.
    PubMed     Abstract available
    
    
    
15. SPYROPOULOS AC, Vedantham S
    Advanced Therapy for Intermediate-Risk Pulmonary Embolism.
    N Engl J Med. 2026 Mar 28. doi: 10.1056/NEJMe2603115.
    PubMed    
    
    
    
16. MOORES LK
    The COBRRA Trial - Ending the Venous Thromboembolism Safety Toss-up.
    N Engl J Med. 2026;394:1123-1124.
    PubMed    
    
    
    
17. CASTELLUCCI LA, Chen VM, Kovacs MJ, Lazo-Langner A, et al
    Bleeding Risk with Apixaban vs. Rivaroxaban in Acute Venous Thromboembolism.
    N Engl J Med. 2026;394:1051-1060.
    PubMed     Abstract available
    
    
    December 2025
18. PIAZZA G
    Extended Treatment of Provoked Venous Thromboembolism. Reply.
    N Engl J Med. 2025;393:2381.
    PubMed    
    
    
    
19. TAZI MEZALEK Z
    Extended Treatment of Provoked Venous Thromboembolism.
    N Engl J Med. 2025;393:2380-2381.
    PubMed    
    
    
    
20. CALVELLO J
    Extended Treatment of Provoked Venous Thromboembolism.
    N Engl J Med. 2025;393:2380.
    PubMed    
    
    
    
21. JACOB SCB, Benedetto IG, Gazzana MB
    Extended Treatment of Provoked Venous Thromboembolism.
    N Engl J Med. 2025;393:2380.
    PubMed    
    
    
    
22. DEMIRCI SAHIN A, Sahin U
    Extended Treatment of Provoked Venous Thromboembolism.
    N Engl J Med. 2025;393:2379.
    PubMed    
    
    
    August 2025
23. PIAZZA G, Bikdeli B, Pandey AK, Krishnathasan D, et al
    Apixaban for Extended Treatment of Provoked Venous Thromboembolism.
    N Engl J Med. 2025 Aug 30. doi: 10.1056/NEJMoa2509426.
    PubMed     Abstract available
    
    
    July 2025
24. MAHE I, Carrier M, Laporte S
    Apixaban for Cancer-Associated Venous Thromboembolism. Reply.
    N Engl J Med. 2025;393:311-312.
    PubMed    
    
    
    
25. CONTEDUCA V, Giordano G, Landriscina M
    Apixaban for Cancer-Associated Venous Thromboembolism.
    N Engl J Med. 2025;393:310-311.
    PubMed    
    
    
    
26. DING YJ, Huang K, Li QY
    Apixaban for Cancer-Associated Venous Thromboembolism.
    N Engl J Med. 2025;393:310.
    PubMed    
    
    
    
27. WU G, Liu W, Sheung L
    Apixaban for Cancer-Associated Venous Thromboembolism.
    N Engl J Med. 2025;393:310.
    PubMed    
    
    
    
28. SHAO Z, Zhai X
    Apixaban for Cancer-Associated Venous Thromboembolism.
    N Engl J Med. 2025;393:309.
    PubMed    
    
    
    March 2025
29. NOBLE S
    Cancer-Associated Venous Thromboembolism - Beyond 6 Months.
    N Engl J Med. 2025 Mar 29. doi: 10.1056/NEJMe2503460.
    PubMed    
    
    
    
30. MAHE I, Carrier M, Mayeur D, Chidiac J, et al
    Extended Reduced-Dose Apixaban for Cancer-Associated Venous Thromboembolism.
    N Engl J Med. 2025 Mar 29. doi: 10.1056/NEJMoa2416112.
    PubMed     Abstract available
    
    
    January 2025
31. SHIMOYAMA Y, Tomoda Y
    Westermark's Sign and Palla's Sign in Pulmonary Embolism.
    N Engl J Med. 2025;392:e2.
    PubMed    
    
    
    August 2024
32. HERON MJ, Deng F
    Lemierre's Syndrome Complicated by Cavernous Sinus Thrombosis.
    N Engl J Med. 2024;391:e12.
    PubMed    
    
    
    November 2023
33. DALY S, Cassidy T
    Thrombus in Transit across a Patent Foramen Ovale.
    N Engl J Med. 2023;389:e45.
    PubMed    
    
    
    July 2023
34. SMYTH R, Kabrhel C, Morris T
    Treatment of Intermediate-Risk Pulmonary Embolism.
    N Engl J Med. 2023;389:184-187.
    PubMed    
    
    
    April 2023
35. O'HARA NN, Stein DM, O'Toole RV
    Aspirin for Thromboprophylaxis after a Fracture. Reply.
    N Engl J Med. 2023;388:e57.
    PubMed    
    
    
    
36. VAN TWIST DJL, Luu IHY, Ten Cate H
    Aspirin for Thromboprophylaxis after a Fracture.
    N Engl J Med. 2023;388:e57.
    PubMed    
    
    
    
37. AHUJA T, Green D
    Aspirin for Thromboprophylaxis after a Fracture.
    N Engl J Med. 2023;388:e57.
    PubMed    
    
    
    
38. YOSHINO T, Yamada Y, Tamura Y
    Aspirin for Thromboprophylaxis after a Fracture.
    N Engl J Med. 2023;388:e57.
    PubMed    
    
    
    
39. WU XD, Min J
    Aspirin for Thromboprophylaxis after a Fracture.
    N Engl J Med. 2023;388:e57.
    PubMed    
    
    
    
40. SOURMELIS S, Zagoreos N
    Aspirin for Thromboprophylaxis after a Fracture.
    N Engl J Med. 2023;388:e57.
    PubMed    
    
    
    March 2023
41. JABAGI MJ, Bertrand M, Botton J, Le Vu S, et al
    Stroke, Myocardial Infarction, and Pulmonary Embolism after Bivalent Booster.
    N Engl J Med. 2023 Mar 29. doi: 10.1056/NEJMc2302134.
    PubMed    
    
    

Thank you for your interest in scientific medicine.

AMEDEO Venous Thrombosis is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum